Matters Requiring Investor Director Approval. So long as the holders of Series A Preferred Stock are entitled to elect a Series A Director, the Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of Directors, which approval must include the affirmative vote of one of the Series A Directors:
Appears in 3 contracts
Samples: Investors’ Rights Agreement (Invea Therapeutics, Inc), Rights Agreement (Syros Pharmaceuticals, Inc.), Rights Agreement (Syros Pharmaceuticals, Inc.)
Matters Requiring Investor Director Approval. So long as the holders of Series A Preferred Stock are entitled to elect a Series A Director, the Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of Directors, which approval must include the affirmative vote of at least one of the Series A Directors:
Appears in 3 contracts
Samples: Investors’ Rights Agreement (Nuvalent, Inc.), Investors’ Rights Agreement (Nuvalent, Inc.), Investors’ Rights Agreement (Lyell Immunopharma, Inc.)
Matters Requiring Investor Director Approval. So long as the holders any shares of Series A Preferred Stock are entitled to elect a Series A Directorremain outstanding, the Company hereby covenants and agrees with each of the Investors that it shall not, without first obtaining the approval of the Board of Directors, which approval must include the affirmative vote of one of all the Series A DirectorsDirectors then in office:
Appears in 3 contracts
Samples: Rights Agreement, Investors’ Rights Agreement (Neon Therapeutics, Inc.), Investors’ Rights Agreement (Neon Therapeutics, Inc.)
Matters Requiring Investor Director Approval. So long as the holders any shares of Series A Preferred Stock are entitled to elect a Series A Directorremain outstanding, the Company hereby covenants and agrees with each of the Investors that it shall not, without first obtaining the approval of the Board of Directors, which approval must include the affirmative vote of one a majority of the Series A Preferred Directors then serving on the Board of Directors:
Appears in 2 contracts
Samples: Investors’ Rights Agreement (Magenta Therapeutics, Inc.), Investors’ Rights Agreement (Magenta Therapeutics, Inc.)
Matters Requiring Investor Director Approval. So long as the holders any shares of Series A Preferred Stock are entitled to elect a Series A Directorremain outstanding, the Company hereby covenants and agrees with each of the Investors that it shall not, without first obtaining the approval of the Board of Directors, which approval must include the affirmative vote of at least one of the Series A DirectorsInvestor Director:
Appears in 2 contracts
Samples: Adoption Agreement (Fulcrum Therapeutics, Inc.), Adoption Agreement (Fulcrum Therapeutics, Inc.)
Matters Requiring Investor Director Approval. So long as the holders of Series A Preferred Stock are entitled to elect a Series A Director, the The Company hereby covenants and agrees with each of the Investors that it shall not, without first obtaining the approval of the Board of Directors, which approval must include include, for so long as any shares of Series A Preferred Stock remain outstanding, the affirmative vote of one of the at least two (2) Series A Directors:Directors (or at least one (1) Series A Director, at any time when there are fewer than two (2) Series A Directors then serving):
Appears in 2 contracts
Samples: Investors’ Rights Agreement (MyoKardia Inc), Investors’ Rights Agreement (MyoKardia Inc)
Matters Requiring Investor Director Approval. So long as the holders any shares of Series A Preferred Stock are entitled to elect a Series A Directorremain outstanding, the Company hereby covenants and agrees with each of the Investors that it shall not, without first obtaining the approval of the Board of Directors, which approval must include the affirmative vote of one both of the Series A Preferred Directors:
Appears in 1 contract
Samples: Investors’ Rights Agreement (Sage Therapeutics, Inc.)
Matters Requiring Investor Director Approval. So long as the holders of Series A Preferred Stock are entitled to elect a Series A Director, the Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of Directors, which approval must include the affirmative vote of one at least four of the Series A Directors:
Appears in 1 contract
Matters Requiring Investor Director Approval. 48 So long as the holders of Series A Preferred Stock are entitled to elect a Series A Director, the Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of Directors, which approval must include the affirmative vote of one [one/both] of the Series A Directors:: 49
Appears in 1 contract
Samples: Investors’ Rights Agreement
Matters Requiring Investor Director Approval. So long as the holders any issued shares of Series A Preferred Stock are entitled to elect a Series A Directorremain outstanding, the Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of Directors, which approval must include the affirmative vote of one (x) a majority of the Series A DirectorsDirectors and (y) the Series B Director:
Appears in 1 contract
Matters Requiring Investor Director Approval. So long as the holders of Series A Preferred Stock are entitled to elect a any Series A DirectorDirectors, the Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of Directors, which approval must include the affirmative vote of at least one (1) of the Series A Directors:
Appears in 1 contract
Samples: Investors’ Rights Agreement (Taysha Gene Therapies, Inc.)
Matters Requiring Investor Director Approval. So long as the holders any shares of Series A Preferred Stock are entitled to elect a Series A Directorremain outstanding, the Company hereby covenants and agrees with each of the Investors that it shall not, without first obtaining the approval of the Board of Directors, which approval must include the affirmative vote of one of the Series A Directors:Directors and, if any, the Series B Director (as defined in the Stockholders Agreement):
Appears in 1 contract
Samples: Investors’ Rights Agreement (Voyager Therapeutics, Inc.)
Matters Requiring Investor Director Approval. So long as the holders of Series A Preferred Stock are entitled to elect a Series A DirectorDirectors, the Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of Directors, which approval must include the affirmative vote of one a majority of the Series A Directors:
Appears in 1 contract
Samples: Investors’ Rights Agreement (Surface Oncology, Inc.)
Matters Requiring Investor Director Approval. So long as the holders any shares of Series A Preferred Stock are entitled to elect a Series A Directorremain outstanding, the Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of DirectorsBoard, which approval must include the affirmative vote of one a majority of the Series A DirectorsPreferred Directors then-serving:
Appears in 1 contract
Samples: Investors’ Rights Agreement (Bolt Biotherapeutics, Inc.)
Matters Requiring Investor Director Approval. So long as the holders any shares of Series A Preferred Stock are entitled to elect a Series A Directorremain outstanding, the Company hereby covenants and agrees with each of the Investors that it shall not, without first obtaining the approval of the Board of Directors, which approval must include the affirmative vote of one of the at least two (2) Series A Directors:Directors (or at least one (1) Series A Director, at any time when there are fewer than two (2) Series A Directors then serving):
Appears in 1 contract
Samples: Investors’ Rights Agreement (Global Blood Therapeutics, Inc.)
Matters Requiring Investor Director Approval. So long as the holders any shares of Series A Preferred Stock are entitled to elect a Series A Directorremain outstanding, the Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of DirectorsBoard, which approval must include the affirmative vote of one a majority of the Series A DirectorsDirectors then-serving:
Appears in 1 contract
Samples: Investors’ Rights Agreement (Aerovate Therapeutics, Inc.)